selected publications
- Translating Science into Survival: Report on the Sixth International Cancer Immunotherapy Conference. Cancer immunology research. 2023 Academic Article GET IT
- Fatty acid metabolism and radiation-induced anti-tumor immunity. International review of cell and molecular biology. 2023 Review GET IT
-
DNA damage repair kinase DNA-PK and cGAS synergize to induce cancer-related inflammation in glioblastoma.
The EMBO journal.
2022
Academic Article
GET IT
Times cited: 3 - Quantification of beta-galactosidase activity as a marker of radiation-driven cellular senescence. Methods in cell biology. 2022 Academic Article GET IT
-
Type I interferon induces cancer stem cells-mediated chemotherapy resistance.
Oncoimmunology.
2022
Comment
GET IT
Times cited: 1 -
Impact of Cryopreservation of Peripheral Blood Stem Cells (PBSC) in Transplantation from Matched Unrelated Donor (MUD).
Journal of clinical medicine.
2022
Academic Article
GET IT
Times cited: 6 -
Halting ErbB-2 isoforms retrograde transport to the nucleus as a new theragnostic approach for triple-negative breast cancer.
Cell death & disease.
2022
Academic Article
GET IT
Times cited: 1 -
ELISA-based quantification of type I IFN secretion by irradiated cancer cells.
Methods in cell biology.
2022
Academic Article
GET IT
Times cited: 1 -
Immunological barriers to immunotherapy in primary and metastatic breast cancer.
EMBO molecular medicine.
2021
Academic Article
GET IT
Times cited: 3 -
Exploiting Radiation Therapy to Restore Immune Reactivity of Glioblastoma.
Frontiers in oncology.
2021
Review
GET IT
Times cited: 103 -
Radiotherapy: An immune response modifier for immuno-oncology.
Seminars in immunology.
2021
Review
GET IT
Times cited: 26 -
Activin A backs-up TGF-ß to promote regulatory T cells.
Oncoimmunology.
2021
Review
GET IT
Times cited: 5 -
Activin A Promotes Regulatory T-cell-Mediated Immunosuppression in Irradiated Breast Cancer.
Cancer immunology research.
2020
Academic Article
GET IT
Times cited: 28 -
Canonical ErbB-2 isoform and ErbB-2 variant c located in the nucleus drive triple negative breast cancer growth.
Oncogene.
2020
Academic Article
GET IT
Times cited: 4 -
Blockade of Stat3 oncogene addiction induces cellular senescence and reveals a cell-nonautonomous activity suitable for cancer immunotherapy.
Oncoimmunology.
2020
Academic Article
GET IT
Times cited: 11 -
Apoptotic Caspases: A Double-Edged Sword in Radiation-Induced Immunogenicity.
Trends in cell biology.
2019
Academic Article
GET IT
Times cited: 3 -
Invasive micropapillary carcinoma of the breast overexpresses MUC4 and is associated with poor outcome to adjuvant trastuzumab in HER2-positive breast cancer.
BMC cancer.
2017
Academic Article
GET IT
Times cited: 18 -
TNFα-Induced Mucin 4 Expression Elicits Trastuzumab Resistance in HER2-Positive Breast Cancer.
Clinical cancer research : an official journal of the American Association for Cancer Research.
2016
Academic Article
GET IT
Times cited: 65 -
Heregulin Co-opts PR Transcriptional Action Via Stat3 Role As a Coregulator to Drive Cancer Growth.
Molecular endocrinology (Baltimore, Md.).
2015
Academic Article
GET IT
Times cited: 12